A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus

Clinical trial NCT05048719 · COMPLETED

Trial details

NCT number: NCT05048719
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2021-09-15
Primary completion: 2022-09-30
Enrollment: 383

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.